Theresa Zesiewicz, MD
Enriched profileProfessor of Neurology, Director of the USF Ataxia Research Center · University of South Florida Morsani College of Medicine
Theresa Zesiewicz is Professor of Neurology, Director of the USF Ataxia Research Center at University of South Florida Morsani College of Medicine. OpenAlex indexes 110 publications with 4,300 citations (h-index 31); ClinicalTrials.gov lists 21 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 18 Oct 2026
Theresa Zesiewicz, MD, is Professor of Neurology, Director of the USF Ataxia Research Center at University of South Florida Morsani College of Medicine. The public record shows 110 publications with 4,300 citations (h-index 31), centered on Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Botulinum Toxin and Related Neurological Disorders. It also documents an investigator role on 21 registered clinical trials, industry payments reported by 11 companies.
- Most recent indexed publication: 2025 · Movement disorders
- Top research focus: Neurological disorders and treatments
- 21 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 50.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 21 registered studies on ClinicalTrials.gov. The most recent:
- Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
Sponsor: PTC Therapeutics
- A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Sponsor: Novartis Pharmaceuticals
Industry payments
Updated 18 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PTC Therapeutics, Inc.Program year20256 payments
- Biogen, Inc.Program year20252 payments
- ABBVIE INC.Program year20255 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
83.4%Neuromuscular Blocker82.6%Onabotulinumtoxina100%Part B, office-administered≥22 patientsgamma-Aminobutyric Acid-ergic Agonist0.5%Baclofen100%Part D<11 patients+ 1 more class in this area
Nervous system
16.1%Aromatic Amino Acid Decarboxylation Inhibitor8.8%Carbidopa-Levodopa62%Carbidopa-Levodopa Er33%Rytary5%Part D<11 patientsNonergot Dopamine Agonist1.5%Ropinirole Hcl50%Pramipexole Dihydrochloride39%Ropinirole Er12%Part D<11 patients+ 13 more classes in this area
Cardiovascular
0.3%Beta blocker0.3%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia.
Movement disorders
Article2025 - Therapies, Research Funding, and Racial Diversity in Essential Tremor: A Systematic Review of the Literature.
Movement disorders clinical practice
Review2022
Most-cited works
by citation count (OpenAlex)- 01Practice Parameter: Therapies for essential tremor [RETIRED]Article373 citations2005
- 02
- 03
- 04Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease [RETIRED]Article273 citations2010
- 05Reliability of a new scale for essential tremorArticle244 citations2012
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/theresa-zesiewicz-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
- Director
USF Ataxia Research Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
James A. Haley Veterans' Administration Parkinson's Disease Clinic, Tampa, FL
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usf.edu ↗ - Director
The Frances J. Zesiewicz Center and Foundation for Parkinson's Disease at USF
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usf.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcast.app ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health